Arkolith/Insider Trading/WVE/Form 4

Takanashi Ken

DirectorWave Life Sciences Ltd. (WVE) · full profile →Form 4 · filed Mar 26, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 23, 2026Conversion(C)3.9M—$09.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 23, 2026Conversion(C)3.9M—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-126276) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML